# EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model

> **NCT00957983** · PHASE1,PHASE2 · COMPLETED · sponsor: **Danish Headache Center** · enrollment: 8 (actual)

## Conditions studied

- Headache, Migraine

## Interventions

- **DRUG:** BGC20-1531

## Key facts

- **NCT ID:** NCT00957983
- **Lead sponsor:** Danish Headache Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2011-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00957983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00957983, "EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00957983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*